chr7-2524746-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001040167.2(LFNG):c.481+3G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000622 in 1,585,924 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
NM_001040167.2 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LFNG | NM_001040167.2 | c.481+3G>A | splice_region_variant, intron_variant | ENST00000222725.10 | NP_001035257.1 | |||
LFNG | NM_001040168.2 | c.481+3G>A | splice_region_variant, intron_variant | NP_001035258.1 | ||||
LFNG | NM_001166355.2 | c.268+3G>A | splice_region_variant, intron_variant | NP_001159827.1 | ||||
LFNG | NM_002304.3 | c.94+3G>A | splice_region_variant, intron_variant | NP_002295.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LFNG | ENST00000222725.10 | c.481+3G>A | splice_region_variant, intron_variant | 5 | NM_001040167.2 | ENSP00000222725.5 |
Frequencies
GnomAD3 genomes AF: 0.00332 AC: 505AN: 152218Hom.: 2 Cov.: 34
GnomAD3 exomes AF: 0.000790 AC: 158AN: 199908Hom.: 1 AF XY: 0.000603 AC XY: 65AN XY: 107854
GnomAD4 exome AF: 0.000335 AC: 480AN: 1433588Hom.: 6 Cov.: 31 AF XY: 0.000279 AC XY: 198AN XY: 710418
GnomAD4 genome AF: 0.00333 AC: 507AN: 152336Hom.: 2 Cov.: 34 AF XY: 0.00307 AC XY: 229AN XY: 74496
ClinVar
Submissions by phenotype
Spondylocostal dysostosis 3, autosomal recessive Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | - - |
LFNG-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at